Insulinlike growth factor binding proteins.

Insulinlike growth factor binding proteins. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Insulinlike growth factor binding proteins. Abstract Text:

Insulinlike growth factor binding proteins (IGFBPs), which are often present in extracellular fluids, have the potential to markedly alter IGF-receptor interaction. There are at least four specific forms of IGFBPs in blood. These forms are also secreted by a number of cell types. Their rates of secretion and clearance appear to be regulated, mostly by hormones. Their major role seems to be to alter the interaction of IGFs with their cell surface receptors. Other functions such as transport out of the vasculature and modulating target cell actions also appear to be important.

Insulinlike growth factor binding proteins. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE: 1990 Nov-Dec

Insulinlike growth factor binding proteins. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Trends in endocrinology and metabolism: TEM

VOLUME: 1

Page Numbers: 412-7

Journal Abbreviation: Trends Endocrinol. Metab.

ISSN: 1043-2760

DAY: 15

MONTH: 04

YEAR: 2008

Insulinlike growth factor binding proteins. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9001516

Insulinlike growth factor binding proteins. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Insulinlike growth factor binding proteins. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Insulinlike growth factor binding proteins.

AFFILIATION: Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Trends Endocrinol Metab

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Insulinlike growth factor binding proteins Related Publications

• Bilateral fractures of the head of the humerus; due to electric shock.
• Detection of oligoclonal bands in cerebrospinal fluid from German Shepherd dogs with degenerative myelopathy by isoelectric focusing and immunofixation.
• Expression of the human beta3 integrin subunit in mouse smooth muscle cells enhances IGF-I-stimulated signaling and proliferation.
• Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-I.
• Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I.
• IGF-I assays: current assay methodologies and their limitations.
• Insulin-like Growth Factor-I Stimulates Shc-dependent Phosphatidylinositol 3-Kinase Activation via Grb2-associated p85 in Vascular Smooth Muscle Cells.
• Insulinlike growth factor binding proteins.
• Integrin-associated protein association with SRC homology 2 domain containing tyrosine phosphatase substrate 1 regulates igf-I signaling in vivo.
• Long-acting forms of growth hormone-releasing hormone and growth hormone: effects in normal volunteers and adults with growth hormone deficiency.
• Measurement of myelin basic protein in the cerebrospinal fluid of dogs with degenerative myelopathy.
• Modulation of integrin antagonist signaling by ligand binding of the heparin-binding domain of vitronectin to the alphaVbeta3 integrin.
• Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.
• Protease-resistant insulin-like growth factor (IGF)-binding protein-4 inhibits IGF-I actions and neointimal expansion in a porcine model of neointimal hyperplasia.
• Regulatory Actions of Insulin-like Growth Factor-binding Proteins.
• Sports Injuries among U.S. Army Soldiers Deployed for Operation Iraqi Freedom: 2182: Board #95 June 1 8:00 AM -9:30 AM.
• The surgical treatment of fractures of the lateral tibial condyle.
• Value of insulin-like growth factor system markers in the assessment of growth hormone status.
• p66shc Negatively Regulates Insulin-Like Growth Factor I Signal Transduction via Inhibition of p52shc Binding to Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase Substrate-1 Leading to Impaired Growth Factor Receptor-Bound Protein-2 Membrane